12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

3K3A-APC: Phase I started

Socratech's ZZ Biotech LLC company began a double-blind, placebo-controlled, Austrian Phase I trial to evaluate single...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >